References
- Akira K, Uchijima F, Hashimoto T. (2002). Rapid internal acyl migration and protein binding of synthetic probenecid glucuronides. Chem Res Toxicol 15:765–72
- Corcoran O, Mortensen RW, Hansen SH, et al. (2001). HPLC/1H NMR spectroscopic studies of the reactive α-1-O-acyl isomer formed during acyl migration of S-naproxen β-1-O-acyl glucuronide. Chem Res Toxicol 14:1363–70
- Guengerich FP, Kim DH, Iwasaki M. (1991). Role of human cytochrome P-450 2E1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168–79
- Obach RS. (2001). Mechanism of cytochrome P4503A4- and 2D6-catalyzed dehydrogenation of Ezlopitant as probed with isotope effects using five deuterated analogs. Drug Metab Dispos 29:1599–607
- Ohtake Y, Sato T, Kobayashi T, et al. (2012). Discovery of Tofogliflozin, a novel C-arylglucoside with an O-spiroketal ring system, as a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. J Med Chem 55:7828–40
- Sams C, Loizou GD, Cocker J, Lennard MS. (2004). Metabolism of ethylbenzene by human liver microsomes and recombinant human cytochrome P450s (CYP). Toxicol Lett 147:253–60
- Sato T, Kobayashi T, Nishimoto M, et al. (2010). Discovery of O-spiroketal C-arylglucosides as novel and selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. Scientific abstracts for the 240th National ACS Meeting and Exposition, Boston, MA, USA, August 22–26, MEDI-202
- Schwab D, Portron A, Backholer Z, et al. (2013). A novel double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]Tofogliflozin after oral administration and concomitant intravenous microdose administration of [13C]Tofogliflozin in humans. Clin Pharmacokinet 52:463–73
- Suzuki M, Honda K, Fukazawa M, et al. (2012). Tofogliflozin, a potent and highly specific sodium/glucose cotransporter 2 inhibitor, improves glycemic control in diabetic rats and mice. J Pharmacol Exp Ther 341:692–701
- World Health Organization. (2013). Diabetes Fact Sheets No 312. World Health Organization Media Centre, Geneva, Switzerland
- Zell M, Husser C. (2009). Drug metabolite identification with UPLC-MS assisted by high resolution reconstructed radiochromatography. Poster MP 452. 57th ASMS Conference on Mass Spectrometry, Philadelphia, PA, USA